These results reveal that the expression of both ANXA9 and ANXA10 is frequently altered in HNSCC and associated to the tumor differentiation grade, suggesting that they could be implicated in the pathogenesis of these cancers. The gene discussed is ANXA9; the disease is head and neck squamous cell carcinoma.